Corporate Site
Skip to main content
Home
Corporate Profile
News Releases
Events & Presentations
Events Calendar
Presentations
Archived Events & Presentation
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Fundamentals
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Beckman Litigation
Cautionary Information
Coronavirus
Please note: Quidel’s new Corporate Headquarters address is 9975 Summers Ridge Road, San Diego, CA 92121.
News Releases
Home
Corporate Profile
News Releases
Events & Presentations
Events Calendar
Presentations
Archived Events & Presentation
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Fundamentals
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Beckman Litigation
Cautionary Information
Coronavirus
Corporate Site
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
12/17/2014
Quidel Receives Simultaneous FDA Clearance and CLIA Waiver for Its Sofia(R) Strep A+ Fluorescent Immunoassay (FIA) via the FDA's New Dual Submission Program
Download
PDF format download (opens in new window)
12/10/2014
Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Bordetella Pertussis
Download
PDF format download (opens in new window)
12/02/2014
Quidel Announces Pricing of $150 Million Convertible Senior Notes Offering
Download
PDF format download (opens in new window)
12/01/2014
Quidel Announces Proposed Offering of $150 Million of Convertible Senior Notes
Download
PDF format download (opens in new window)
11/18/2014
Dr. Kenneth J. Widder Joins Quidel's Board of Directors
Download
PDF format download (opens in new window)
10/21/2014
Quidel Reports Third Quarter 2014 Financial Results
Download
PDF format download (opens in new window)
10/15/2014
Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Human Parainfluenza Viruses (HPIV), Types 1, 2 and 3
Download
PDF format download (opens in new window)
10/13/2014
Quidel Receives FDA Clearance for Its Lyra(R) Molecular PCR Assay for the Detection of Adenovirus
Download
PDF format download (opens in new window)
10/06/2014
Quidel to Hold Third Quarter 2014 Financial Results Conference Call on October 21, 2014
Download
PDF format download (opens in new window)
08/22/2014
Quidel to Present at Baird 2014 Health Care Conference
Download
PDF format download (opens in new window)
07/28/2014
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
Download
PDF format download (opens in new window)
07/22/2014
Quidel Reports Second Quarter 2014 Financial Results
Download
PDF format download (opens in new window)
07/08/2014
Quidel to Hold Second Quarter 2014 Financial Results Conference Call on July 22, 2014
Download
PDF format download (opens in new window)
06/04/2014
Quidel to Present at Wells Fargo Securities 2014 Healthcare Conference
Download
PDF format download (opens in new window)
06/02/2014
Quidel Receives CLIA Waiver for Its Sofia(R) Diagnostic Test for Respiratory Syncytial Virus (RSV)
Download
PDF format download (opens in new window)
05/14/2014
Quidel Receives FDA Clearance for Its Molecular PCR Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus
Download
PDF format download (opens in new window)
04/29/2014
Quidel to Present at Bank of America Merrill Lynch 2014 Health Care Conference
Download
PDF format download (opens in new window)
04/23/2014
Quidel Reports First Quarter 2014 Financial Results
Download
PDF format download (opens in new window)
04/22/2014
Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Infections From Pyogenic Streptococcus Group A and C or G
Download
PDF format download (opens in new window)
04/15/2014
Quidel to Hold First Quarter 2014 Financial Results Conference Call on April 23, 2014
Download
PDF format download (opens in new window)
03/27/2014
Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Herpes Simplex Virus Types 1 and 2
Download
PDF format download (opens in new window)
02/18/2014
Quidel to Present at Cowen 34th Annual Health Care Conference
Download
PDF format download (opens in new window)
02/11/2014
Quidel Reports Fourth Quarter and Full Year 2013 Financial Results
Download
PDF format download (opens in new window)
01/28/2014
Quidel to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on February 11, 2014
Download
PDF format download (opens in new window)
01/08/2014
Quidel Announces Preliminary Revenue for Fourth Quarter 2013
Download
PDF format download (opens in new window)